PolyGel LLC Welcomes Two Dynamic Leaders to Its Team

PolyGel LLC Welcomes Two Dynamic Leaders to Its Team

PolyGel LLC, a leading innovator in gel wellness products, is proud to announce the addition of two highly experienced professionals, Carrie Kovacs and Anna Hibschman Ferguson, to its team. Their extensive expertise and proven track records will undoubtedly bolster PolyGel's efforts in sales and... - May 04, 2024 - PolyGel LLC

Pagari Life Science Corp. Announces the Commercial Launch of Helocaine®, a New Transformative Cold Sore Treatment

Pagari Life Science Corp. Announces the Commercial Launch of Helocaine®, a New Transformative Cold Sore Treatment

Pagari Life Science Corporation is revolutionizing cold sore treatment with the commercial launch of Helocaine®. - May 01, 2024 - Pagari Life Sciences

AMPP Advocacy Day 2024: Championing Corrosion Control on Capitol Hill

AMPP, a leader in materials protection, hosts its Advocacy Day in Washington, D.C., on May 15-16, 2024, to influence legislation. - May 01, 2024 - AMPP

Eugene B. Caldona, Ph.D., Wins AMPP’s Prestigious 2024 Dr. A. John Sedriks Seed Grant Award

AMPP has named Eugene B. Caldona, Ph.D. from North Dakota State University as the 2024 recipient of the Dr. A. John Sedriks Seed Grant. - May 01, 2024 - AMPP

Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease

Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease

AnzuBridge® updates its CDMS to enhance biotech evaluations with advanced video tools, ensuring precise efficacy recording and compliance. It supports scalable trials and features HIPAA-compliant media capture, ePRO for patient engagement, and sophisticated video review capabilities, all integrated with a Learning Management System for efficient trial management. - April 30, 2024 - Anzu

No More Acetone: Thar Process Develops Clean and Green Process to Create Sterile, Fat-Free Lecithin Powder and GMP Quality Oils for Human Consumption

No More Acetone: Thar Process Develops Clean and Green Process to Create Sterile, Fat-Free Lecithin Powder and GMP Quality Oils for Human Consumption

Thar Process, with 34 years of expertise in supercritical fluid extraction, has developed a sustainable way to produce de-fatted lecithin powder that has less oil and longer shelf-life stability. The new process is semi-continuous and sustainable because it utilizes upcycled CO2 from waste sources instead of using toxic acetone which is the industry standard. - April 26, 2024 - Thar Process, LLC

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This... - April 25, 2024 - ALPCO

AMPP Leads Worldwide Social Media Blitz for World Corrosion Awareness Day

On April 24, 2024, the "Corrosion Around the Clock" campaign, led by AMPP and partners, will feature synchronized global LinkedIn posts to highlight corrosion challenges and promote international unity. - April 20, 2024 - AMPP

AMPP Launches French-Language Basic Coatings Inspector Certification and Ethics eCourse

AMPP launches its Basic Coatings Inspector Certification and Ethics for the Corrosion Professional eCourse in French, targeting French-speaking professionals and meeting new regulatory demands. - April 19, 2024 - AMPP

Ease.io Announces 2023 Champions for Quality Winners

The Champions for Quality Awards honor individuals, manufacturing sites, and entire companies for their role in fostering a culture of excellence and establishing enduring quality processes that beneficially affect the bottom line, customer satisfaction and consumer experience. These accolades are based on publicly submitted nominations from manufacturers globally and data from the EASE plant floor audit and inspection platform, spanning eight distinct categories. - April 18, 2024 - Ease Inc.

Flow Research Finds Worldwide Flowmeter Market Continuing to Climb

Flow Research Finds Worldwide Flowmeter Market Continuing to Climb

A new study from Flow Research, Volume X: The World Market for Flowmeters, 9th Edition (www.flowvolumex.com), finds that the worldwide flowmeter market is strong and trending upward as the economy continues to grow and rising oil prices drive exploration and production. Other forces, such as continued population growth and economic expansion, are also fueling growth. Coriolis and magnetic flowmeters are the revenue leaders in the flowmeter market. - April 18, 2024 - Flow Research, Inc.

Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development

Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development

Mirror Biologics, Inc., a clinical stage biopharmaceutical company announces the appointment of Elizabeth Adkins Czerepak as Chief Financial Officer (CFO) and Vice President of Corporate Development effective April 15, 2024. Ms. Czerepak has served as CFO of several biotechnology companies over... - April 18, 2024 - Mirror Biologics, Inc.

CANEI Ranked as the Top Recycling Company on the Financial Times list of Americas' Fastest-Growing Companies in 2024

CANEI is especially proud to have been included in the waste management and recycling category, as it is a unique achievement within its industry. The recognition it has received is a testament to its unwavering commitment to closing the loop on plastic waste. - April 17, 2024 - CANEI Corporation

I Holland Unveils TSAR 2: Advancing Predictive Modelling in Tablet Compression

I Holland proudly announces the development of TSAR 2, an advanced predictive model developed through a collaborative partnership between academia and industry. Building upon the success of the Tabletting Science Anti-Stick Research (TSAR) project, I Holland continues its groundbreaking research... - April 12, 2024 - I Holland Ltd.

Boiron’s New Arnicare® Wellness Kits Offer Holistic Approach to Pain Management

Boiron, world leader in homeopathic medicines, introduces its new Arnicare Wellness Kits as convenient and comprehensive solutions for painsleep and stress relief. The kits are designed to provide individuals with daytime and nighttime options to manage pain with occasional sleeplessness and... - April 11, 2024 - Boiron

Huntington Study Group Launches Project AWARE 2.0 Observational Study

Huntington Study Group Launches Project AWARE 2.0 Observational Study

The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group

Minus K Congratulates to the Winners of Their 2023/2024 Educational Giveaway

Minus K congratulates the four winners of the Minus K's 2023/2024 Educational Giveaway. Over $75,000 of new passive mechanical hub hertz vibration isolators have been granted to universities and colleges in the U.S. over the last ten years. - April 10, 2024 - Minus K Technology Inc.

AMPP Unveils New Guide to Enhance Pipeline Safety Through Corrosion Control, Aligning with Latest PHMSA Regulations

AMPP published Guide 21569-2024, by SC 15, enhancing onshore gas pipeline safety and integrity in line with PHMSA's new regulations. - April 10, 2024 - AMPP

FuseBio Presents New Data at AACR: Targeting a Functionally-Selective IL-18 (F-18) to PD-1: A Next Generation Checkpoint Inhibitor with Enhanced Anti-Tumor Activity

FuseBio's unique attenuation mechanism renders IL-18, a functionally selective IL-18, resistant to IL-18BP and 1 million percent less active in circulation and yet still retain nearly full activity when targeted to PD-1+/IL-18R+ cells, the key functional immune cells in tumors. It is designed to retain full activity of PD-1 checkpoint blockade and simultaneously deliver a functionally selective IL-18 (F-18) to preserve and enhance the anti-tumor activity of immune cells. - April 09, 2024 - Fuse Biotherapeutics

Ombra Group Acquires 75% of IUT Medical GmbH to Propel Next-Generation Gas and Chemical Detection

Ombra Group Inc, a global pioneer in advanced technology solutions, today announced its acquisition of IUT Medical GmbH, a world-renowned German company specializing in cutting-edge gas and hazardous chemical detection systems. Founded in 1998 by the late Prof. Dr. Jürgen Leonhardt, IUT... - April 09, 2024 - The Ombra Group Inc.

Perma-Fix Successfully Completes Pilot Plant Testing and Unveils New Process for Destruction of PFAS “Forever Chemicals”

Perma-Fix Environmental Services, Inc. (the “Company”) today announced it has successfully completed pilot plant testing on its new, patent-pending process for the destruction of Per- and Polyfluorinated Substances (PFAS), commonly known as “forever chemicals.” - April 08, 2024 - Perma-Fix

Renowned Advocate Lorrinda Gray-Davis to Speak at TRIO's Remember & Rejoice Event

Renowned Advocate Lorrinda Gray-Davis to Speak at TRIO's Remember & Rejoice Event

As a guest speaker, Lorrinda Gray-Davis will share her personal journey of hope, resilience, and gratitude, highlighting the profound impact of organ donation on individuals, families, and communities. "Remember & Rejoice" stands as the single largest gathering of donor families and transplant recipients in the country, providing a sacred space for reflection, remembrance, and rejoicing. - April 06, 2024 - TRIO-Oklahoma

AMPP 2024: Triumph, Innovation, and Solidarity Define the Annual Conference + Expo in New Orleans

The 2024 AMPP Conference in New Orleans highlighted achievements, resilience, and global industry unity against challenges. - April 06, 2024 - AMPP

Groundbreaking Research Validates Biome Makers’ BeCrop Soil Intelligence Technology

Biome Makers, a global agtech company, proudly announces its contribution to the publication of two scientific studies validating the efficacy and reliability of the company’s revolutionary technology. These landmark papers demonstrate a significant leap forward in the field of soil health intelligence and predicting soil functionality. - April 06, 2024 - Biome Makers

Ngram Expands AI Dataset Offerings with Descriptive Question Answering for Healthcare

Ngram Expands AI Dataset Offerings with Descriptive Question Answering for Healthcare

New open-source medchat-qa-descriptive dataset enables AI models to provide comprehensive answers to complex medical queries. - March 22, 2024 - ngram Inc.

Parvus Announces Collaboration with AbbVie to Develop IBD Therapies Based on the Parvus Navacim Platform Technology

The collaboration will combine AbbVie’s expertise in Immunology with Parvus’ innovative Navacim™ regulatory T cells (Treg) immune tolerization platform technology to develop therapies for Inflammatory Bowel Disease Parvus Therapeutics announced today that it has entered into an... - March 20, 2024 - Parvus Therapeutics U.S., Inc.

AMD Stopper, a New Treatment for Age-Related Macular Degeneration, Seeks Partnerships with Manufacturers in the Healthcare Industry

AMD Stopper, a New Treatment for Age-Related Macular Degeneration, Seeks Partnerships with Manufacturers in the Healthcare Industry

California inventor of oral treatment for Age-Related Macular Degeneration, a common eye disease which affects tens of millions globally, is working tirelessly to bring his formulation to market. - March 20, 2024 - AMD Stopper

Ease.io Boosts Growth Trajectory with Strategic Appointment of Russell Mullin as Chief Revenue Officer

This pivotal hire underscores Ease.io's commitment to scaling its global footprint and further accelerating product expansion and adoption among manufacturers worldwide. - March 19, 2024 - Ease Inc.

ACL Digital and PhoenixAI.tech Partner to Take AI-Driven Drone Technology to New Heights

The strategic partnership enhances ACL Digital’s capabilities with PhoenixAI.tech, focusing on AI drone solutions for UAVs, IoT, and edge computing to revolutionize operations significantly Beyond Visual Line of Sight (BVLOS) missions. - March 16, 2024 - ACL Digital

iView Therapeutics Inc. Announced FDA’s Clearance of IND Application for IVW-1001 Ophthalmic Eyelid Wipe to Treat Signs and Symptoms of Dry Eye Disease

iView Therapeutics Inc. Announced FDA’s Clearance of IND Application for IVW-1001 Ophthalmic Eyelid Wipe to Treat Signs and Symptoms of Dry Eye Disease

iView Therapeutics Inc., a clinical stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, announces that the U.S. Food and Drug Administration (FDA) cleared iView’s Investigational New Drug (IND) application to for the initiation of a Phase 1/2 clinical... - March 11, 2024 - iView Therapeutics Inc.

Defined Bioscience Introduces Ready-CEPT™: A New Cell Viability Enhancer

Defined Bioscience is pleased to announce the launch of Ready-CEPT™ 1000X, a new product designed to improve stem cell survival, growth, and health during critical processes such as routine passaging, cryopreservation, and freeze-thaw recovery. - March 11, 2024 - Defined Bioscience Inc.

Utech Products Inc. Achieves ISO 9001

Utech Products Inc. Achieves ISO 9001 Certification (Certification Registration No. 961 24 5889), Demonstrating Commitment to Quality and Customer Satisfaction. - March 09, 2024 - Utech Products Inc.

New Guide from EU Automation: Reducing Costs and Boosting Uptime with Condition-Based Maintenance and Real-Time Monitoring

Automation parts supplier EU Automation has published a new guide for engineers wanting to deploy condition-based maintenance (CBM) to improve operating efficiencies and increase profitability. It provides valuable insight so engineers can best implement a CBM strategy to realise its full benefits. - March 01, 2024 - EU Automation

IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024

IVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024

IVIEW Therapeutics Inc. announces to present the positive topline result in the Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis in the upcoming 2024 ARVO (The Association for Research in Vision and Ophthalmology) national meeting in Seattle, WA. The Presentation... - February 28, 2024 - iView Therapeutics Inc.

Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies

Cayman Chemical introduces the latest addition to the company’s portfolio of lipid nanoparticle (LNP) research tools for academic, pharma, and biotech researchers worldwide. The LipidLaunch™ product line helps researchers pursue LNPs for the delivery of nucleic acid therapies in untold health applications, ranging from vaccine development to cancer and cell or gene therapies. - February 22, 2024 - Cayman Chemical Company

AMPP Announces Winners of the 3rd Annual Diversity and Inclusion Grants

AMPP has announced the winners of its 3rd Annual Diversity and Inclusion Grants. - February 16, 2024 - AMPP

Gotham Biotech’s Histoplasma Urinary Antigen EIA Kit Now Available for Purchase as Histoplasma Spreads in the U.S.

Gotham Biotech’s Histoplasma Urinary Antigen EIA Kit Now Available for Purchase as Histoplasma Spreads in the U.S.

Histoplasmosis is a systemic disease caused by the thermally dimorphic fungus Histoplasma capsulatum. H. capsulatum is distributed worldwide and endemic to the Ohio and Mississippi River Valleys, where the CDC estimates 60% to 90% of people who live in the region have been exposed to the fungus at some point during their life, and to certain regions of Central and South America. Medicare records from 2007 to 2016 have found cases of histoplasmosis have now spread to 47 states and Washington, DC. - February 15, 2024 - Gotham Biotech

GENINVO, a Leading Provider of Life Science Product and Business Solutions Announced the Offering of Its On-Demand Service/Tool: ApoGI™

ApoGI™ is an integrated, one stop automation platform that leverages Artificial Intelligence and Machine Learning algorithms to focus on standards and metadata driven generation of artifacts. The Primary objective of this platform is to help SMEs (Subject matter experts) focus on curating... - February 15, 2024 - GenInvo, Inc.

AMPP Champions Leadership and Inclusion at 2024 Annual Conference + Expo with Valuing Voices Forum

AMPP aims to provide its members with valuable events designed to empower leaders and promote diversity, equity, and inclusion (DEI) in the workplace at the AMPP Annual Conference and Expo. - February 15, 2024 - AMPP

AMPP Welcomes New Board Member to Strengthen Its Commitment to the Transportation Sector

AMPP welcomes Todd Bennett to its Board of Directors, effective immediately. This addition is a key step in deepening AMPP's commitment to the transportation sector. - February 15, 2024 - AMPP

NAD3® Supplement Study: Memphis Health Sciences College Discovers Key to Cellular Rejuvenation

NAD3® Supplement Study: Memphis Health Sciences College Discovers Key to Cellular Rejuvenation

In a groundbreaking development, the College of Health Sciences at the University of Memphis, spearheaded by leading researchers Janine Hellenbrand, Richard J. Bloomer, and Marie Van der Merwe, has revealed the remarkable effects of NAD3® supplementation on adult stem cell circulation in... - February 14, 2024 - High Performance Nutrition

Biopharmaceutical Sponsor Interaction with Clinical Site Networks Pulse Report

Sponsor Outsourcing Dollars May Shift to Clinical Site Networks, Transforming the CRO Relationship - February 13, 2024 - Life Science Strategy Group, LLC

Microvascular Therapeutics Welcomes Thom Tulip as Chief Business Officer

Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing the next generation of microbubbles unlocking the therapeutic potential of ultrasound, proudly announces the appointment of Dr Thom Tulip as their new Chief Business Officer. In this pivotal role, Dr Tulip will lead capital raises to propel MVT's cutting-edge technologies into the market. - February 10, 2024 - Microvascular Therapeutics, Inc.

Flow Circuits and Rapid Fluidics Ltd. Announce Partnership to Drive Microfluidic Innovation

Flow Circuits design platform and Rapid Fluidics 3D Print capabilities perfectly complement each other for rapid fluidic system development. Combined they empower researchers in diverse markets such as Pharmaceutical & Life Sciences Research, Point of Care Testing and Clinical Diagnostics, and Environment and Industrial Analytics. - February 05, 2024 - Rapid Fluidics Ltd

Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston

AI to Take Center Stage at Bio-IT World Conference & Expo, the Hub for Pharmaceutical, Biotech and IT Collaboration - February 04, 2024 - Cambridge Healthtech Institute

RIOT Wireless Tank Level Monitoring Solution Honored for Excellence in Innovation

The RIOT Edge Solutions’ Wireless tank-level monitoring solution utilizes a fully integrated, rugged tank level monitoring device, mobile app and remote visibility via API, allowing enterprise users to integrate sensor data in their own or preferred visualization and automation tools as well as processes. - February 04, 2024 - RIOT Edge Solutions

SocoFlame, Inc. (a Subsidiary of Groupe Socomore) Completes Acquisition of the Flamemaster Corporation

SocoFlame, Inc. (a subsidiary of Groupe Socomore) announced that it has closed its acquisition of the Flamemaster Corporation following the completion of its previously announced tender offer for all outstanding shares of common stock of the Flamemaster Corporation. SocoFlame, Inc. (a subsidiary of... - February 02, 2024 - Flamemaster Corporation

Patient Experience and Satisfaction with Electronic Consent, Onboarding, and Diaries in Clinical Trials Report

New Market Research Shows Different Patient Preferences for Electronic Diaries - January 31, 2024 - Life Science Strategy Group, LLC

Ease.io Marks a Stellar 2023 with Industry-Leading Achievements and Robust Growth

Ease.io experienced substantial user expansion, high customer satisfaction, and industry recognition, underscoring its commitment to advancing manufacturing quality and safety. - January 29, 2024 - Ease Inc.

Second Anniversary of Fern Hollow Bridge Collapse Highlights Urgent Need for Corrosion Control in National Infrastructure

On January 28, 2024, the second anniversary of the Fern Hollow bridge collapse near Frick Park in Pittsburgh will be observed, a tragedy that highlighted significant vulnerabilities in America's infrastructure, particularly emphasizing the critical issue of corrosion. - January 28, 2024 - AMPP

Press Releases 1 - 50 of 5,953